Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-06-08
1996-05-14
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514253, 546 77, 546 78, 546 61, 544361, A61K 3149
Patent
active
055167799
ABSTRACT:
Compounds of the formula ##STR1## are inhibitors of 5 .alpha.-reductase and are useful alone or in combination with other active agents for the treatment of hyperandrogenic disorders such as acne vulgaris, seborrhea, female hirsutism, male pattern baldness, and benign prostatic hyperplasia.
REFERENCES:
patent: 4337584 (1983-03-01), Rasmusson et al.
patent: 5438061 (1995-08-01), Bergman et al.
Helliker, Wall St. Jour 7 Jun. 1991, pp. A1, A7.
Stinson, Chem & Eng News 29 Jun. 1992 pp. 7-8.
Diani, Jour Clin, Endo. & Metab. vol. 74 pp. 345-350 (1992).
J. Med. Chem., 6-Azasteroids; Potent Dual Inhibitors of Human Type 1 and 2 Steroid 5-Alpha-Reductase, Frye et al., 1993, vol. 36, 4313-4315.
G. Harris, et al., Pro. Natl. Acad. Sci., vol. 89, pp. 10787-10791, (1992).
C. D. Jones, et al., J. Med. Chem., vol. 36, pp. 421-423 (1993).
G. H. Rusmusson, et al., J. Med. Chem., vol. 29 pp. 2298-2315 (1986).
Graham Donald W.
Langen Derek Von
Tolman Richard L.
Daus Donald G.
Fitch Catherine D.
Giesser Joanne M.
Merck & Co. , Inc.
Winokur Melvin
LandOfFree
17.beta.-substituted-6-azasteroid derivatives useful as 5.alpha. does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 17.beta.-substituted-6-azasteroid derivatives useful as 5.alpha., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 17.beta.-substituted-6-azasteroid derivatives useful as 5.alpha. will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1895898